Lugano, Switzerland, 25 June 2025 – The ESMO Gastrointestinal Cancers Congress 2025 will take place between 2-5 July in Barcelona, bringing together leading experts to present new data, share insights, and discuss recent development in the understanding and treatment of gastrointestinal malignancies. The Congress will cover a broad spectrum of topics – from molecular prevention and precision therapy to patient-centred approaches and quality of life. Congress sessions will be held onsite and will also be live streamed via the Virtual Congress Platform.

Programme picks

• New data on the efficacy, safety, and impact on patients’ quality of life of a combined immunotherapy in the treatment of hepatocellular carcinoma and colorectal cancer.
  • Related content: LBA3, 1O, 148O

• Findings on the use of ctDNA in colorectal cancer care, including liquid biopsy-guided selection of patients for anti-EGFR re-treatment.
  • Related content: 2O, 3O, 4O, 6MO, 15P, 16P, 17P, 19P, 42P

• New combination therapies expand treatment options for hepatocellular carcinoma patients with specific genetic markers or poor prognosis.
  • Related content: 149MO, 150MO

• Results on overall survival for gastric cancer patients with CDH1 pathogenic variant undergoing surveillance.
  • ​​​​​​​Related content: 393MO

• Insights on specificities and challenges of early-onset colorectal cancer (EOCRC): from molecular footprint and clinical features to potential biomarkers for early detection and the need for earlier screening.
  • ​​​​​​​​​​​​​​Related content: 70P, 77P, 79P, 80P, 82P, Special Symposium

Keynote Sessions

• “Molecular biology insights in pancreatic cancer", by Anirban Maitra and

• “Epidemiology: Trends and causes of gastrointestinal cancers” by Elisabete Weiderpass 2 July, 13:00 - 14:00 CEST

• “Decoding genome and transcriptome signatures in colorectal cancer”, by Federica Di Nicolantonio, 3 July, 10:00 - 10:30 CEST

• “Blood tests for colorectal cancer screening and more wide cancer screening” by Frank A. Sinicrope, 4 July, 10:00 - 10:30 CEST

The abstracts will be published online as a supplement to Annals of Oncology. The abstract titles can be viewed through the online programme.

Press accreditation
ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities and the embargo schedule for ESMO Gastrointestinal Cancers Congress 2025. To apply for press accreditation, please fill out the form available here. Please be kindly informed that onsite press accreditation will not be available.

Third Parties Media registration
Third Parties Media representatives and Filming Crews not eligible as press, must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org).